About: Etazolate

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org:8891

Etazolate (SQ-20,009, EHT-0202) is an anxiolytic drug which is a pyrazolopyridine derivative and has unique pharmacological properties. It acts as a positive allosteric modulator of the GABAA receptor at the barbiturate binding site, as an adenosine antagonist of the A1 and A2 subtypes, and as a phosphodiesterase inhibitor selective for the PDE4 isoform. It is currently in clinical trials for the treatment of Alzheimer's disease.

Property	Value
dbo:abstract	Etazolate (SQ-20,009, EHT-0202) is an anxiolytic drug which is a pyrazolopyridine derivative and has unique pharmacological properties. It acts as a positive allosteric modulator of the GABAA receptor at the barbiturate binding site, as an adenosine antagonist of the A1 and A2 subtypes, and as a phosphodiesterase inhibitor selective for the PDE4 isoform. It is currently in clinical trials for the treatment of Alzheimer's disease. (en)
dbo:casNumber	51022-77-6
dbo:chEBI	138502
dbo:chEMBL	356388
dbo:fdaUniiCode	I89Y79062L
dbo:pubchem	3277
dbo:thumbnail	wiki-commons:Special:FilePath/Etazolate.svg?width=300
dbo:wikiPageID	16399269 (xsd:integer)
dbo:wikiPageLength	6845 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1118268852 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Cartazolate dbr:Mouth dbc:Pyrazolopyridines dbc:PDE4_inhibitors dbr:Pharmacology dbc:GABAA_receptor_positive_allosteric_modulators dbr:Pyrazolopyridine dbr:Anxiolytic dbr:Clinical_trial dbr:Receptor_antagonist dbr:Positive_allosteric_modulator dbr:Barbiturate dbc:Adenosine_receptor_antagonists dbr:Adenosine_A1_receptor dbr:Tracazolate dbr:Drug dbr:GABAA_receptor dbr:Adenosine dbc:Anxiolytics dbr:Alzheimer's_disease dbr:Isoform dbc:Ethyl_esters dbr:Adenosine_A2_receptor_(disambiguation) dbr:Binding_site dbc:Hydrazones dbr:ICI-190,622 dbr:PDE4 dbr:Phosphodiesterase_inhibitor dbr:Chemical_derivative dbr:File:Cartazolate&Etazolate_synthesis.png
dbp:atcPrefix	none (en)
dbp:c	14 (xsd:integer)
dbp:casNumber	51022 (xsd:integer)
dbp:chebi	138502 (xsd:integer)
dbp:chembl	356388 (xsd:integer)
dbp:chemspiderid	3162 (xsd:integer)
dbp:h	19 (xsd:integer)
dbp:iupacName	Ethyl 1-ethyl-4-[2-hydrazinyl]-1H-pyrazolo[3,4-b]pyridine-5-carboxylate (en)
dbp:iupharLigand	7336 (xsd:integer)
dbp:legalStatus	Uncontrolled (en)
dbp:n	5 (xsd:integer)
dbp:o	2 (xsd:integer)
dbp:pubchem	3277 (xsd:integer)
dbp:routesOfAdministration	dbr:Mouth
dbp:smiles	CCN1C2=NC=CCOCC (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	OPQRBXUBWHDHPQ-UHFFFAOYSA-N (en)
dbp:unii	I89Y79062L (en)
dbp:wikiPageUsesTemplate	dbt:Phosphodiesterase_inhibitors dbt:Adenosinergics dbt:Drugbox dbt:GABAAR_PAMs dbt:Reflist dbt:Short_description dbt:Fdacite dbt:Anxiolytics
dcterms:subject	dbc:Pyrazolopyridines dbc:PDE4_inhibitors dbc:GABAA_receptor_positive_allosteric_modulators dbc:Adenosine_receptor_antagonists dbc:Anxiolytics dbc:Ethyl_esters dbc:Hydrazones
gold:hypernym	dbr:Drug
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAnxiolytics yago:WikicatMolecularFormulas yago:WikicatPDE4Inhibitors yago:Abstraction100002137 yago:Agent114778436 yago:CausalAgent100007347 yago:Communication100033020 yago:Drug103247620 yago:DrugOfAbuse103248958 yago:Formula106816935 yago:Inhibitor114724436 yago:Matter100020827 yago:Medicine103740161 yago:Message106598915 yago:MinorTranquilizer103771443 yago:MolecularFormula106817173 yago:PhysicalEntity100001930 yago:PsychotropicAgent104017429 dbo:Drug yago:Sedative-hypnotic104166841 yago:Sedative104166553 yago:Statement106722453 yago:Substance100020090 yago:Tranquilizer104470232 umbel-rc:DrugProduct
rdfs:comment	Etazolate (SQ-20,009, EHT-0202) is an anxiolytic drug which is a pyrazolopyridine derivative and has unique pharmacological properties. It acts as a positive allosteric modulator of the GABAA receptor at the barbiturate binding site, as an adenosine antagonist of the A1 and A2 subtypes, and as a phosphodiesterase inhibitor selective for the PDE4 isoform. It is currently in clinical trials for the treatment of Alzheimer's disease. (en)
rdfs:label	Etazolate (en)
owl:sameAs	freebase:Etazolate yago-res:Etazolate wikidata:Etazolate dbpedia-sh:Etazolate dbpedia-sr:Etazolate https://global.dbpedia.org/id/4jbow dbr:Etazolate
prov:wasDerivedFrom	wikipedia-en:Etazolate?oldid=1118268852&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Cartazolate&Etazolate_synthesis.png wiki-commons:Special:FilePath/Etazolate.svg
foaf:isPrimaryTopicOf	wikipedia-en:Etazolate
is dbo:wikiPageRedirects of	dbr:C14H19N5O2
is dbo:wikiPageWikiLink of	dbr:Cartazolate dbr:Pyrazolopyridine dbr:C14H19N5O2 dbr:Tracazolate dbr:GABA_receptor_agonist dbr:List_of_MeSH_codes_(D03) dbr:ICI-190,622 dbr:List_of_drugs:_Et
is foaf:primaryTopic of	wikipedia-en:Etazolate